2013 | Impact of ABCC2, ABCG2 and SLCO1B1 polymorphisms on the pharmacokinetics of pitavastatin in humans
| DRUG METABOLISM AND PHARMACOKINETICS |
2012 | The UGT1A3*2 polymorphism affects atorvastatin lactonization and lipid-lowering effect in healthy volunteers | PHARMACOGENETICS AND GENOMICS |
2012 | Influence of ABCC2, SLCO1B1, and ABCG2 Polymorphisms on the Pharmacokinetics of Olmesartan | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY |
2012 | Modeling of the LDL cholesterol-lowering effect of atorvastatin in Korean dyslipidemic patients and non-patient volunteers | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS |
2012 | Effects of cytochrome P450 (CYP)2C19 polymorphisms on pharmacokinetics of phenobarbital in neonates and infants with seizures | ARCHIVES OF DISEASE IN CHILDHOOD |
2011 | Pharmacokinetic comparison of sustained- and immediate-release oral formulations of cilostazol in healthy Korean subjects: a randomized, open-label, 3-part, sequential, 2-period, crossover, single-dose, food-effect, and multiple-dose study | CLINICAL THERAPEUTICS |
2011 | Safety and pharmacokinetics of intrathecal administration of pemetrexed in rats | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2011 | Rifampin enhances the glucose-lowering effect of metformin and increases OCT1 mRNA levels in healthy participants | CLINICAL PHARMACOLOGY & THERAPEUTICS |
2011 | Effects of pregnane X receptor (NR1I2) and CYP2B6 genetic polymorphisms on the induction of bupropion hydroxylation by rifampin.
| DRUG METABOLISM AND DISPOSITION |
2011 | Effect of CYP2B6 genotype on the pharmacokinetics of sibutramine and active metabolites in healthy subjects | JOURNAL OF CLINICAL PHARMACOLOGY |
2010 | PEG-인터페론 알파-2a 제제 DA-3021의 안전성 및 약동력학적 특성 연구
| Journal of Korean Society for Clinical Pharmacology and Therapeutics (임상약리학회지) |
2010 | Comparison of the bioavailability and tolerability of fixed-dose combination glimepiride/metformin 2/500-mg tablets versus separate tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy Korean volunteers | CLINICAL THERAPEUTICS |
2010 | CYP3A5*3 genotype associated with intrasubject pharmacokinetic variation toward tacrolimus in bioequivalence study | THERAPEUTIC DRUG MONITORING |
2010 | Effects of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of atorvastatin and 2-hydroxyatorvastatin in healthy Korean subjects | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS |
2009 | 가교자료 생성을위한 약동학 시험
| Journal of Korean Society for Clinical Pharmacology and Therapeutics (임상약리학회지) |